The resulting αCSPG4(scFv)-MAP tau was similarly evaluated for binding and internalization in CSPG4+ human triple-negative breast cancer (TNBC) cell lines, alongside CSPG4− mammary carcinoma lines. Here, CSPG4 is linked to breast carcinoma.